To support the neurosurgery community in these unprecedented times, the CNS is offering complimentary online education. Learn more.

  • Effects of transexamic acid on Patients with acute traumatic brain injury: the CRASH3 trial

    Transexamic acid (TXA) has been demonstrated to reduce mortality significantly in patients with extracranial bleeding by inhibiting fibrinolysis to reduce hemorrhage.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy